PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 158 filers reported holding PRECIGEN INC in Q1 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | +24.7% | 64,210 | +0.8% | 0.00% | – |
| Q2 2023 | $73 | +7.4% | 63,699 | 0.0% | 0.00% | – |
| Q1 2023 | $68 | -31.3% | 63,699 | -2.6% | 0.00% | – |
| Q4 2022 | $99 | -99.9% | 65,399 | -0.0% | 0.00% | – |
| Q3 2022 | $139,000 | +59.8% | 65,407 | +0.5% | 0.00% | – |
| Q2 2022 | $87,000 | -37.0% | 65,113 | -0.3% | 0.00% | – |
| Q1 2022 | $138,000 | -43.0% | 65,331 | +0.0% | 0.00% | – |
| Q4 2021 | $242,000 | -94.4% | 65,327 | -92.5% | 0.00% | -100.0% |
| Q3 2021 | $4,330,000 | -24.9% | 867,746 | -1.8% | 0.01% | -16.7% |
| Q2 2021 | $5,764,000 | -2.6% | 884,034 | +3.0% | 0.01% | -14.3% |
| Q1 2021 | $5,916,000 | +928.9% | 858,632 | +1422.4% | 0.01% | +600.0% |
| Q4 2020 | $575,000 | +191.9% | 56,400 | 0.0% | 0.00% | – |
| Q3 2020 | $197,000 | -29.9% | 56,400 | 0.0% | 0.00% | – |
| Q2 2020 | $281,000 | +46.4% | 56,400 | 0.0% | 0.00% | – |
| Q1 2020 | $192,000 | – | 56,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |